Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1. [electronic resource]
Producer: 20130321Description: 1183-94 p. digitalISSN:- 1940-6215
- Adipose Tissue -- cytology
- Animals
- Aromatase -- chemistry
- BRCA1 Protein -- genetics
- Blotting, Western
- Breast Neoplasms -- drug therapy
- Cells, Cultured
- Chromatin Immunoprecipitation
- Cyclic AMP -- metabolism
- Cyclic AMP-Dependent Protein Kinases -- metabolism
- Dinoprostone -- metabolism
- Electrophoretic Mobility Shift Assay
- Female
- Gene Expression Regulation, Enzymologic
- Humans
- Hydroxyprostaglandin Dehydrogenases -- genetics
- Hypoglycemic Agents -- pharmacology
- Mice
- PPAR gamma -- agonists
- Pioglitazone
- Promoter Regions, Genetic -- genetics
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Snail Family Transcription Factors
- Thiazolidinediones -- pharmacology
- Transcription Factors -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.